Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families

Journal of Medical Genetics

Volumn 35, Issue 3, 1998, Pages 196-201

  Robinson, R ^a   Curran, J L ^b,c   Hall, W J ^b,c   Halsall, P J ^b   Hopkins, P M ^b   Markham, A F ^c   Stewart, A D ^a   West, S P ^d   Ellis, F R ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Northern Regional Genetics Service   (United Kingdom)

Author keywords

Generic heterogeneity; HOMOG; Malignant hyperthermia

Indexed keywords

RYANODINE RECEPTOR;

ARTICLE; CHROMOSOME 19Q; COMPUTER PROGRAM; FAMILY STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTHERMIA; MARKER GENE; PRIORITY JOURNAL; RECEPTOR GENE; UNITED KINGDOM;

EID: 0031922519     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.3.196     Document Type: Article

References (12)

1. Ellis FR, Halsall PJ, Harriman DGF. The work of the Leeds Malignant Hyperpyrexia Investigation Unit, 1971-1984. Anaesthesia 1984;41:809-15.
2. MacLennan DH, Duff C, Zorzato F, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559-61.
3. McCarthy TV, Healy JMS, Heffron JJA, et al. Localisation of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990;343:562-4.
4. Stewart AD, Hall JL, Taylor GR, et al. Genetic linkage analysis using microsatellites in human malignant hyperthermia. Human Gene Mapping 11. Cytogenet Cell Genet 1991;58:2025.
5. Ball SP, Dorkins HR, Ellis FR, et al. Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia. Br J Anaes 1993;70:70-5.
6. Couch FJ, Gillard BF, MacLennan DH, et al. Linkage mapping of malignant hyperthermia to the skeletal muscle ryanodine receptor (RYR1) on chromosome 19. Human Gene Mapping 11. Cytogenet Cell Genet 1991;58:2018.
7. Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in the porcine ryanodine receptor that is associated with MH. Science 1991;253:448-51.
8. Otsu K, Khanna VK, Archibald AL, MacLennan DH. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families. Genomics 1991;11:744-50.
9. Healy JMS, Heffron JJA, Lehane M, Bradley DG, Johnson K, McCarthy TV. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers. BMJ 1991;303: 1225-8.
10. Levitt RC, Nouri N, Jedlicka AE, et al. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics 1991;11:543-7.
11. Deufel T, Golla A, lies D, et al. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet 1992;50:1151-61.
12. Fagerlund T, Islander G, Ranklev E, et al. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet 1992;41:270-2.